tetrasodium-meso-tetra(4-sulfonatophenyl)porphine

Modify Date: 2025-08-26 18:32:43

tetrasodium-meso-tetra(4-sulfonatophenyl)porphine Structure
tetrasodium-meso-tetra(4-sulfonatophenyl)porphine structure
Common Name tetrasodium-meso-tetra(4-sulfonatophenyl)porphine
CAS Number 39050-26-5 Molecular Weight 1022.92
Density 1.607g/cm3 Boiling Point N/A
Molecular Formula C44H26N4Na4O12S4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of tetrasodium-meso-tetra(4-sulfonatophenyl)porphine


TSPP tetrasodium is a photosensitizer that has shown impressive effects in in vivo regression of cancer and microorganism infections (Ex: 413 nm, Em: 640 nm)[1][2].

 Names

Name meso-Tetrakis(p-sulfophenyl)porphine tetrasodium salt
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.607g/cm3
Molecular Formula C44H26N4Na4O12S4
Molecular Weight 1022.92
Exact Mass 957.06400
PSA 307.30000
LogP 8.17620
Appearance of Characters Powder | purple

 MSDS


Section 1: Product Identification
Chemical Name:Tetrasodium-meso-tetra(4-sulfonatophenyl)porphine dodecahydrate, min. 95%
CAS Registry Number:39050-26-5
Formula:C44H26N4Na4O12S4.12H2O
EINECS Number:none
Chemical Family:metal porphine (porphyrin) complex
Synonym:none

Section 2: Composition and Information on Ingredients
IngredientCAS NumberPercentACGIH (TWA)OSHA (PEL)
Title Compound39050-26-5100%no datano data

Section 3: Hazards Identification
Emergency Overview:No particular hazard associated with this material.
Primary Routes of Exposure:Ingestion, inhalation
Eye Contact:May cause slight to mild irritation of the eyes.
Skin Contact:May cause slight to mild irritation of the skin.
Inhalation:May be irritating to the nose, mucous membranes and respiratory tract.
Ingestion:No specific information is available on the physiological effects of ingestion.
Acute Health Affects:May be irritating to skin, eyes and respiratory tract.
Chronic Health Affects:No information available on long-term chronic effects.
NTP:No
IARC:No
OSHA:No

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:no data
Autoignition Temperature:none
Explosion Limits:none
Extinguishing Medium:carbon dioxide, dry powder or foam
If this material is involved in a fire, fire fighters should be equipped with a NIOSH approved, positive pressure
Special Fire Fighting Procedures:
self contained breathing apparatus and full protective clothing.
Hazardous Combustion andIf involved in a fire this material may emit toxic organic fumes.
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:Small spills can be mixed with vermiculite or sodium carbonate and swept up.

SECTION 7: Handling and Storage
Handling and Storage:Store in a tightly sealed container. Keep away from heat and direct sunlight.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:Wear protective clothes and gloves. Consult glove manufacturer to determine the proper type of glove.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation:Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Additional Protection:No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:purple pwdr.
Molecular Weight:1022.87 (1239.11)
Melting Point:no data
Boiling Point:no data
Vapor Pressure:not applicable
Specific Gravity:no data
Odor:none
Solubility in Water:very soluble

SECTION 10: Stability and Reactivity
Stability:air and moisture stable solid
Hazardous Polymerization:no hazardous polymerization
Conditions to Avoid:none
Incompatibility:oxidizing agents
Decomposition Products:carbon dioxide, carbon monoxide, nitrogen oxides, sulfur dioxide, organic fumes, and sodium oxide

SECTION 11: Toxicological Information
RTECS Data:No information available in the RTECS files.
Carcinogenic Effects:No data available
Mutagenic Effects:No data available
Tetratogenic Effects:No data available

SECTION 12: Ecological Information
Ecological Information:No information available

SECTION 13: Disposal Considerations
Disposal:Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):Non-hazardous
Hazard Class (CFR):NA
Additional Hazard Class (CFR):NA
Packaging Group (CFR):NA
UN ID Number (CFR):NA
Shipping Name (IATA):Non-hazardous
Hazard Class (IATA):NA
Additional Hazard Class (IATA):NA
Packaging Group (IATA):NA
UN ID Number (IATA):NA

SECTION 15: Regulatory Information
TSCA:Listed in the TSCA inventory.
SARA (Title 313):Not reportable under SARA Title 313
Second Ingredient:none


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Synonyms

tetrasodium-meso-tetra(4-sulfonatophenyl)porphinedodecahydrate,min.
Na4[H2tpps]
5,10,15,20-Tetrakis[4-(sodiooxysulfonyl)phenyl]-21H,23H-porphyrin
TETRASODIUM-MESO-TETRA(4-SULFONATOPHENYL)PORPHINE DODECAHYDRATE
5,10,15,20-Tetrakis[4-(sodiosulfo)phenyl]-21H,23H-porphyrin
5,10,15,20-Tetraphenyl-21H,23H-porphine-p,p',p'',p'''-tetrasulfonic acid tetrasodium salt
TETRASODIUM-MESO-TETRA(4-SULFONATOPHENYL)PORPHINE
5,10,15,20-Tetrakis(sodium 4-sulfonatophenyl)-21H,23H-porphyrin
meso-Tetrakis-(4-sulfophenyl)-porphine tetrasod
tetrasodium meso-5,10,15,20-tetrakis(p-sulfonatophenyl)porphyrin sodium
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

tetrasodium-meso-tetra(4-sulfonatophenyl)porphine suppliers


Price: ¥600/100 mg

Reference only. check more tetrasodium-meso-tetra(4-sulfonatophenyl)porphine price

Related Compounds: More...
TETRASODIUM-MESO-TETRA(4-SULFONATOPHENYL)PORPHINE
39174-47-5
Tetrasodium-meso-tetra(4-sulfonatophenyl)porphinedodecahydrate
50849-45-1
Tetrasodium-meso-tetra(4-sulfonatophenyl)porphinedodecahydrate
110452-48-7
Sn(IV) meso-Tetra (4-Pyridyl) Porphine Dichloride
87261-83-4
PD(II) MESO-TETRA(4-CARBOXYPHENYL)PORPHINE
94288-44-5
Pt(II) meso-Tetra (4-carboxyphenyl) porphine
94288-45-6
Cu(II) meso-Tetra(4-carboxyphenyl)porphine
41699-93-8
Tetrakis (4-carboxyphenyl) porphyrin
14609-54-2
4,4',4'',4'''-(Porphyrin-5,10,15,20-tetrayl)tetrakis(N,N-dimethylaniline)
14945-24-5
2-Cyclopropyl-5-ethyl-4-methyl-6-{4-[4-(trifluoromethyl)pyrimidin-2-yl]piperazin-1-yl}pyrimidine
2640971-09-9
4-[4-(5-Bromopyrimidin-2-yl)piperazin-1-yl]-2-tert-butyl-5-fluoro-6-methylpyrimidine
2640948-49-6
5-Methyl-4-{[1-(6-methylpyrimidin-4-yl)piperidin-4-yl]methoxy}-2-(methylsulfanyl)pyrimidine
2640945-07-7
2-Methyl-4-[4-({[5-methyl-2-(methylsulfanyl)pyrimidin-4-yl]oxy}methyl)piperidin-1-yl]pyrimidine
2640889-28-5
4-Methyl-2-[4-({[5-methyl-2-(methylsulfanyl)pyrimidin-4-yl]oxy}methyl)piperidin-1-yl]pyrimidine
2640966-97-6
5-Methyl-2-[4-({[5-methyl-2-(methylsulfanyl)pyrimidin-4-yl]oxy}methyl)piperidin-1-yl]pyrimidine
2640873-85-2
5-Methyl-4-({1-[(5-methyl-1,2-oxazol-3-yl)methyl]piperidin-4-yl}methoxy)-2-(methylsulfanyl)pyrimidine
2640899-34-7
4-Cyclopropyl-2-(methylsulfanyl)-6-(4-{[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]methyl}piperazin-1-yl)pyrimidine
2640898-75-3
4-[(4-{2-methyl-5H,6H,7H-cyclopenta[d]pyrimidin-4-yl}piperazin-1-yl)methyl]benzonitrile
2640899-41-6
6-(3a-{[(5-Methylpyrimidin-2-yl)oxy]methyl}-octahydrocyclopenta[c]pyrrole-2-carbonyl)-2-methyl-2,3-dihydropyridazin-3-one
2640892-62-0